Suboxone Snorting: Risks, Dangers & Correct Use
Snorting Suboxone: Dangerous and Ineffective
Suboxone (buprenorphine/naloxone) is formulated for sublingual/buccal administration. Snorting it is misuse with serious risks.
Why Sublingual?
Buprenorphine has poor oral bioavailability but good transmucosal absorption. Naloxone is minimally absorbed sublingually but blocks opioid effects if injected—deterrent.
Snorting Risks
- Rapid absorption → overdose: Bypasses first-pass; high peak levels → respiratory depression, sedation, death.
- Nasal damage: Ulceration, septal perforation, chronic sinusitis.
- Precipitated withdrawal: Naloxone absorption may trigger withdrawal in opioid-dependent users.
- Inconsistent dosing: Powder variability → unpredictable effects.
- Addiction reinforcement: Rapid onset reinforces compulsive use.
Correct Use
Place film/tablet under tongue or against cheek until dissolved (5–10 min). No eating/drinking 15 min before/after. Follow prescriber's dosing exactly.
Help
If misusing, tell your provider. Treatment adjustment, counseling, or higher care level may be needed. SAMHSA: 1-800-662-HELP.
Breathwork - Related Articles
- Brain Control of Breathing: Medullary & Pontine Centers, Chemoreceptors & Voluntary Override
- Shortness of Breath and Headaches: Seek Medical Care Immediately
- Postpartum Shortness of Breath: Causes from Anemia to Peripartum Cardiomyopathy
- Tactile Stimulation for Neonatal Apnea: Technique and Rationale
- Gunshot Lung Injury: Pulmonary Contusion, Pneumothorax, Hemothorax
- Unconscious but Breathing: First Aid Steps & Emergency Response
- CPR: Mouth‑to‑Mouth & Chest Compression Steps
